Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Nature Medicine|March 4, 2022
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trialLaurence Chu, Keith Vrbicky, David Montefiori, et al.
Cancer|October 4, 2019
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108Peter H O'Donnell, Hendrick Tobias Arkenau, Srikala S Sridhar, et al.
Infectious Diseases and Therapy|November 16, 2024
Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in AdultsCatherine A Panozzo, Edward E Walsh, Zhen Yang, et al.
Human Vaccines & Immunotherapeutics|April 2, 2025
An mRNA-based seasonal influenza vaccine in adults: Results of two phase 3 randomized clinical trials and correlate of protection analysis of hemagglutination inhibition titersBoris Kandinov, Mieke Soens, Wenmei Huang, et al.
Nature Medicine|September 16, 2021
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysisAngela Choi, Matthew Koch, Kai Wu, et al.
The Journal of Infectious Diseases|June 18, 2024
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older AdultsJaya Goswami, Abdullah H Baqui, Pablo A Doreski, et al.
The New England Journal of Medicine|December 13, 2023
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older AdultsEleanor Wilson, Jaya Goswami, Abdullah H Baqui, et al.
Pageof 2